|
2024
|
Invention
|
Crystal form or salt of bicyclic heteroaryl amide compound, preparation method therefor and use t... |
|
|
Invention
|
Rnai agent for inhibiting expression of lpa and use of rnai agent. Provided is an RNAi agent for ... |
|
|
Invention
|
Cyclic amine derivative, and composition and use thereof. The present invention relates to a cycl... |
|
|
Invention
|
Cyclohexane derivative, pharmaceutical composition thereof and use thereof. 131A1A receptor, for ... |
|
2023
|
Invention
|
Ligand-oligonucleotide conjugate and linker for conjugate. A ligand-oligonucleotide conjugate and... |
|
2022
|
Invention
|
Fused bicyclic heteroaryl amide compound as protein aggregation inhibitor.
Provided are a fused ... |
|
|
Invention
|
Fused bicyclic heteroaryl amide compound as protein aggregation inhibitor. Provided are a fused b... |
|
2020
|
Invention
|
Blood coagulation factor xia inhibitor. A blood coagulation factor XIa inhibitor of formula I, a ... |
|
2016
|
Invention
|
Substituted ureas and methods of treating mental illness using the same. 2 receptors, and can be ... |
|
|
Invention
|
Cyclohexane derivative or stereoisomer or salt thereof, and preparation and use thereof. Provided... |
|
2015
|
Invention
|
Process for preparing (1s)-1-phenyl-3,4-dihydro-2(1h)-isoquinoline-carboxylate. A process for pre... |
|
2014
|
Invention
|
Process for preparing cinacalcet hydrochloride. Method for preparing cinacalcet hydrochloride hav... |
|
|
Invention
|
Ticagrelor monohydrate, preparation method therefor and use thereof in pharmacy. Disclosed is a t... |
|
2013
|
Invention
|
Preparation method of (1s)-1-phenyl-3,4-dihydro-2(1h)-isoquinoline carboxylate. Provided is a pre... |
|
|
Invention
|
Method of preparing cinacalcet hydrochloride. The present invention provides a method of preparin... |
